Sputum PCR-single-strand conformational polymorphism test for same-day detection of pyrazinamide resistance in tuberculosis patients

Journal of Clinical Microbiology

Volumn 47, Issue 9, 2009, Pages 2937-2943

  Sheen, Patricia ^a   Méndez, Melissa ^a   Gilman, Robert H ^a,b   Peña, Lizeth ^a   Caviedes, Luz ^a   Zimic, Mirko J ^a   Zhang, Ying ^b   Moore, David A J ^a,b,c   Evans, Carlton A ^a,b,c  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACCURACY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; COST; DIAGNOSTIC TEST; DNA SEQUENCE; GENE MUTATION; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; SINGLE STRAND CONFORMATION POLYMORPHISM; SPUTUM ANALYSIS; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PYRAZINAMIDE; SENSITIVITY AND SPECIFICITY; SPUTUM; TIME FACTORS; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 69949086826     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01594-08     Document Type: Article

References (26)

1. Brennan, P. J. 2008. Handbook of anti-tuberculosis agents. Tuberculosis 88:85-170.
2. Corbett, E. L., C. J. Watt, N. Walker, D. Maher, B. G. Williams, M. C. Raviglione, and C. Dye. 2003. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch. Intern. Med. 163:1009-1021.
3. Davies, A. P., O. J. Billington, T. D. McHugh, D. A. Mitchison, and S. H. Gillespie. 2000. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis. J. Clin. Microbiol. 38:3686-3688.
4. Endoh, T., A. Yagihashi, N. Uehara, D. Kobayashi, N. Tsuji, M. Nakamura, S. Hayashi, N. Fujii, and N. Watanabe. 2002. Pyrazinamide resistance associated with pncA gene mutation in Mycobacterium tuberculosis in Japan. Epidemiol. Infect. 128:337-342.
5. Hewlett, D., Jr., D. L. Horn, and C. Alfalla. 1995. Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing. JAMA 273:916-917.
6. Hirano, K., M. Takahashi, Y. Kazumi, Y. Fukasawa, and C. Abe. 1997. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tuber. Lung Dis. 78:117-122.
7. Hou, L., D. Osei-Hyiaman, Z. Zhang, B. Wang, A. Yang, and K. Kano. 2000. Molecular characterization of pncA gene mutations in Mycobacterium tuberculosis clinical isolates from China. Epidemiol. Infect. 124:227-232.
8. Kent, P. T., and G. P. Kubica. 1985. Public health mycobacteriology: a guide for the level III laboratory. USDHHS, Centers for Disease Control and Prevention, Atlanta, GA.
9. McClatchy, J. K., A. Y. Tsang, and M. S. Cernich. 1981. Use of pyrazinamidase activity on Mycobacterium tuberculosis as a rapid method for determination of pyrazinamide susceptibility. Antimicrob. Agents Chemother. 20:556-557.
10. Montenegro, S. H., R. H. Gilman, P. Sheen, R. Cama, L. Caviedes, T. Hopper, R. Chambers, and R. A. Oberhelman. 2003. Improved detection of Mycobacterium tuberculosis in Peruvian children by use of a heminested IS6110 polymerase chain reaction assay. Clin. Infect. Dis. 36:16-23.
11. Moore, D. A., C. A. Evans, R. H. Gilman, L. Caviedes, J. Coronel, A. Vivar, E. Sanchez, Y. Pinedo, J. C. Saravia, C. Salazar, R. Oberhelman, M. G. Hollm-Delgado, D. LaChira, A. R. Escombe, and J. S. Friedland. 2006. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N. Engl. J. Med. 355:1539-1550.
12. Park, S. K., J. Y. Lee, C. L. Chang, M. K. Lee, H. C. Son, C. M. Kim, H. J. Jang, H. K. Park, and S. H. Jeong. 2001. pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea. BMC Infect. Dis. 1:4.
13. Ramaswamy, S. V., R. Reich, S. J. Dou, L. Jasperse, X. Pan, A. Wanger, T. Quitugua, and E. A. Graviss. 2003. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47:1241-1250.
14. Raviglione, M. C., R. Gupta, C. M. Dye, and M. A. Espinal. 2001. The burden of drug-resistant tuberculosis and mechanisms for its control. Ann. N. Y. Acad. Sci. 953:88-97.
15. Salfinger, M., and L. B. Heifets. 1988. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method. Antimicrob. Agents Chemother. 32:1002-1004.
16. Scorpio, A., P. Lindholm-Levy, L. Heifets, R. Gilman, S. Siddiqi, M. Cynamon, and Y. Zhang. 1997. Characterization of pncA mutations in pyrazinamide- resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 41:540-543.
17. Scorpio, A., and Y. Zhang. 1996. Mutations in pncA, a gene encoding pyrazinamidase/ nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat. Med. 2:662-667.
18. Telenti, A., N. Honore, C. Bernasconi, J. March, A. Ortega, B. Heym, H. E. Takiff, and S. T. Cole. 1997. Genotypic assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol. 35:719-723.
19. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650. (Pubitemid 23083244)
20. Telenti, A., P. Imboden, F. Marchesi, T. Schmidheini, and T. Bodmer. 1993. Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob. Agents Chemother. 37:2054-2058.
21. Trivedi, S. S., and S. G. Desai. 1987. Pyrazinamidase activity of Mycobacterium tuberculosis-a test of sensitivity to pyrazinamide. Tubercle 68:221-224.
22. van Soolingen, D., P. W. Hermans, P. E. de Haas, D. R. Soll, and J. D. van Embden. 1991. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J. Clin. Microbiol. 29:2578-2586.
23. Vásquez-Campos, L., L. Asencios-Solis, E. Leo-Hurtado, N. Quispe-Torres, E. Salazar-Lindo, J. Bayona, and M. C. Becerra. 2004. Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001. Int. J. Tuberc. Lung Dis. 8:465-472.
24. Wu, X., J. Zhang, and M. Zhong. 2000. Studies on pncA gene mutations in M. tuberculosis isolates. Zhonghua Jie He He Hu Xi Za Zhi 23:40-42.
25. Zhang, Y., and D. Mitchison. 2003. The curious characteristics of pyrazinamide: a review. Int. J. Tuberc. Lung Dis. 7:6-21.
26. Zhang, Y., S. Permar, and Z. Sun. 2002. Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J. Med. Microbiol. 51:42-49.